RT Journal Article
SR Electronic
T1 Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.08.20095943
DO 10.1101/2020.05.08.20095943
A1 Ortiz-Prado, Esteban
A1 Simbaña-Rivera, Katherine
A1 Diaz, Ana Maria
A1 Barreto, Alejandra
A1 Moyano, Carla
A1 Arcos, Vannesa
A1 Vásconez-González, Eduardo
A1 Paz, Clara
A1 Simbaña-Guaycha, Fernanda
A1 Molestina-Luzuriaga, Martin
A1 Fernández-Naranjo, Raúl
A1 Feijoo, Javier
A1 Henriquez, Aquiles R.
A1 Adana, Lila
A1 López Cortés, Andrés
A1 Fletcher, Isabel
A1 Lowe, Rachel
A1 Gómez-Barreno, Lenin
YR 2020
UL http://medrxiv.org/content/early/2020/05/18/2020.05.08.20095943.abstract
AB Background The SARS-CoV-2 virus has spread rapidly around the globe. Nevertheless, there is limited information describing the characteristics and outcomes of COVID-19 patients in Latin America.Methods We conducted a cross-sectional analysis of 9,468 confirmed COVID-19 cases reported in Ecuador. We calculated overall incidence, mortality, case fatality rates, disability adjusted life years, attack and crude mortality rates, as well as relative risk and relative odds of death, adjusted for age, sex and presence of comorbidities.Results A total of 9,468 positive COVID-19 cases and 474 deaths were included in the analysis. Men accounted for 55.4% (n = 5, 247) of cases and women for 44.6% (n = 4, 221). We found the presence of comorbidities, being male and older than 65 years were important determinants of mortality. Coastal regions were most affected by COVID-19, with higher mortality rates than the highlands. Fatigue was reported in 53.2% of the patients, followed by headache (43%), dry cough (41.7%), ageusia (37.1%) and anosmia (36.1%).Conclusion We present the first analysis of the burden of COVID-19 in Ecuador. Our findings show that men are at higher risk of dying from COVID-19 than women, and risk increases with age and the presence of comorbidities. We also found that blue-collar workers and the unemployed are at greater risk of dying. These early observations offer clinical insights for the medical community to help improve patient care and for public health officials to strengthen Ecuador’s response to the outbreak.Competing Interest StatementEsteban Ortiz-Prado was invited to advise the government during the first week of the pandemic, nevertheless, this invitation was carried out to many others scientists who did not receive any economic retribution for their work and this temporary role did not interfere with the analysis of the results in any way. The other authors have no conflict of interest to declare.Funding StatementThis work was funded by the Universidad de Las Americas throughout their annual general research projects funds.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is included as part of the submission